New chemo combo aims to cut Long-Term harm in kids with AML
Disease control
Recruiting now
This study tests whether replacing two standard chemotherapy cycles with new drug combinations is safe and effective for children and young adults with acute myeloid leukemia (AML) at intermediate or high risk of relapse. About 36 participants will receive the new cycles and be m…
Phase: EARLY_PHASE1 • Sponsor: Joanna Yi • Aim: Disease control
Last updated May 17, 2026 03:11 UTC